Genetic Testing and Asian Patients:
What You Need to Know About Your Psychiatric Medications
Why Genetics Matter for Asian Patients in Psychiatry
If you are of Asian descent, your genetic makeup may affect how your body handles certain psychiatric medications differently than patients of other backgrounds. This is not about race being a risk factor for mental illness. It is about the fact that certain gene variants are more common in Asian populations, and these variants can change how medications are processed in your body or whether certain medications carry additional safety risks.
Genetic testing before starting psychiatric medications can help your provider make safer, more personalized treatment decisions. Here is what you should know.
How Asian Patients May Process Medications Differently
CYP2C19: A Key Gene for Antidepressants
One of the most important genes in psychiatric medication metabolism is called CYP2C19. This gene helps your body break down many common antidepressants, including escitalopram (Lexapro), citalopram (Celexa), and sertraline (Zoloft).
Research shows that the CYP2C19 loss-of-function gene variants (*2 and *3) are significantly more common in East Asian populations. The *2 variant is found in about 30% of East Asians compared to about 15% in White populations, and the *3 variant, which is rare in White populations, is much more common in East Asian individuals.
What this means for you
If you carry these gene variants, you may be a "poor metabolizer" or "intermediate metabolizer," meaning your body breaks down certain antidepressants more slowly. This can lead to higher drug levels in your blood at standard doses, which may increase the risk of side effects. More than half of the East Asian population carries at least one of these variants. Your provider may need to start you at a lower dose or choose a different medication altogether based on your results.
CYP2D6: Important for Antipsychotics and Some Antidepressants
Another important gene is CYP2D6, which helps break down medications like aripiprazole (Abilify), risperidone (Risperdal), haloperidol (Haldol), and some antidepressants like paroxetine (Paxil) and venlafaxine (Effexor).
In East and Southeast Asian populations, the CYP2D6*10 variant is very common, found in up to 70% of some populations. This variant is associated with reduced enzyme activity, meaning many Asian patients are intermediate metabolizers for CYP2D6. This can lead to higher than expected blood levels of these medications at standard doses.
The HLA Gene: A Critical Safety Test
HLA-B*1502 and Serious Skin Reactions
This is one of the most important reasons for genetic testing in Asian patients. The HLA-B*1502 gene variant is found at much higher rates in people of Southeast Asian and East Asian descent, particularly those of Han Chinese, Thai, Malaysian, Filipino, and Indian ancestry. This variant is rare in people of European or African descent.
Important safety information
Carrying HLA-B*1502 significantly increases the risk of a rare but potentially life-threatening skin reaction called Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). These reactions cause severe blistering and peeling of the skin and can be fatal. The FDA requires HLA-B*1502 testing before starting carbamazepine in patients of Asian ancestry.
The medications most strongly linked to this risk include:
- Carbamazepine (Tegretol): The strongest association. Patients who test positive should NOT take carbamazepine.
- Oxcarbazepine (Trileptal): Also strongly associated. Should be avoided in HLA-B*1502 positive patients.
- Lamotrigine (Lamictal): Has a milder but still significant association (approximately 2 to 3 times higher risk of SJS/TEN in HLA-B*1502 positive patients). The FDA recommends weighing the risks and benefits carefully.
- Phenytoin (Dilantin): Also carries increased risk.
HLA-A*3101 and Carbamazepine
Another HLA variant, HLA-A*3101, is associated with carbamazepine-induced hypersensitivity reactions, particularly in Japanese and Korean populations. This variant is linked to a broader range of reactions, including milder rashes and drug reaction with eosinophilia and systemic symptoms (DRESS).
What About Lamotrigine? Is It Off the Table?
This is a common and important question. Lamotrigine is one of the most widely used mood stabilizers for bipolar disorder, and it is understandable to be concerned.
The short answer: Lamotrigine is not automatically off the table for all Asian patients, but it requires careful screening first.
- If you test negative for HLA-B*1502, lamotrigine can generally be used with the same precautions as for any other patient (slow dose titration, watching for rash).
- If you test positive for HLA-B*1502, the decision becomes more nuanced. The FDA states that the risks and benefits should be carefully weighed. Many experts recommend avoiding lamotrigine in this case, though it is not listed as an absolute contraindication.
- Regardless of HLA status, all patients starting lamotrigine should follow a slow dose escalation schedule and be closely monitored for any rash, especially in the first 2 to 8 weeks.
Bottom line: Get tested first. If you are HLA-B*1502 negative, lamotrigine remains a good option. If you are positive, talk to your provider about alternative mood stabilizers.
Medications That May Need Dose Adjustments in Asian Patients
Based on genetic testing results, your provider may adjust doses for the following commonly prescribed psychiatric medications:
| Medication | Gene | Impact in Asian Patients |
|---|---|---|
| Escitalopram & Citalopram | CYP2C19 | Poor metabolizers may have drug levels more than 2.5x higher. Lower starting doses often recommended. |
| Sertraline | CYP2C19 | Intermediate metabolizers show about 38% higher drug exposure. Dose adjustments may be needed. |
| Aripiprazole | CYP2D6 | Poor and intermediate metabolizers show about 48% higher drug exposure. The FDA label recommends dose reduction. |
| Risperidone | CYP2D6 | Poor and intermediate metabolizers show about 36% higher drug exposure. |
| Haloperidol | CYP2D6 | Poor metabolizers show about 68% higher drug exposure. |
What Should You Do?
- Ask your provider about genetic testing before starting a new psychiatric medication, especially if you are of Asian descent.
- Get HLA-B*1502 testing before starting carbamazepine, oxcarbazepine, lamotrigine, or phenytoin. This is a simple cheek swab or blood test.
- Do not stop any current medication without talking to your provider first, even if you learn you carry a risk variant. If a medication is working well for you, your provider may decide the benefits outweigh the risks.
- Share your results with all your providers. Your genetic results are lifelong and relevant to any future prescribing decisions.
Remember: Genetic testing is one tool among many. Your provider considers your symptoms, medical history, other medications, and your own experiences when making treatment decisions.
The Bigger Picture
Genetic testing in psychiatry is still a growing field, and much of the existing research has been conducted primarily in European populations. Asian-specific pharmacogenomic research is expanding, and recommendations from an Asian perspective are now being developed to better serve these populations. The goal is simple: to make psychiatric treatment safer and more effective for everyone, regardless of background.
Alice Tran, PMHNP-BC offers genetic testing and culturally informed psychiatric care for patients of Asian descent across Virginia. Book an appointment or send a message with questions.
See also: Understanding Your Genetic Test: A Patient Guide · The Asian Mental Health Care Gap · Services at Alice Tran Psychiatric Care
Anh Tran (Alice), PMHNP, FNP-BC
Dual Board-Certified Family and Psychiatric Nurse Practitioner
Alice is a dual board-certified PMHNP and FNP licensed in Virginia. She earned dual master's degrees in psychiatric and family nursing and completed advanced clinical training under Dr. Errol Segall, MD, a highly respected psychiatrist with more than 50 years of experience. Alice provides compassionate, evidence-based psychiatric care through secure telehealth appointments across Virginia, with an office conveniently located in Northern Virginia. She is committed to providing culturally responsive care and is fluent in both English and Vietnamese. Learn more →